Greenwood Capital Associates sold 21.9% of its Johnson & Johnson holdings in Q1, reducing their stake by over 15,000 shares.

Berkshire Hathaway’s energy portfolio is a tale of two strategies—one bold, one beautifully boring—and the latter is winning ...

Oracle just dropped its fiscal 2025 curtain and is already hyping fiscal 2026 with cloud-powered ambition. Morgan Stanley ...

AbbVie’s price target got a fresh boost as Citigroup raised it to $205, joining a chorus of analysts expressing optimism.